A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in ...
Japanese researchers used a nonviral piggyBac system to genetically modify cynomolgus monkeys, enabling more accurate disease ...
MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...
LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...
Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death ...
4d
AZoLifeSciences on MSNEnhanced Embryo Screening Efficiency in Primate Genetic ModificationGenetic engineering in non-human primates has historically faced limitations due to the reliance on virus-based gene delivery methods.
The following is a summary of “Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization ...
According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results